← Back to Search

Voice tremor for Muscle Tension Voice Disorder

N/A
Recruiting
Led By Kristina Simonyan, MD, PhD
Research Sponsored by Kristina Simonyan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Summary

This trial is using a novel approach to study how brain changes and genetic risk factors are related in laryngeal dystonia, in the hopes of better understanding the disorder and improving clinical management.

Eligible Conditions
  • Muscle Tension Voice Disorder
  • Spasmodic Dysphonia
  • Unaffected Relatives of Laryngeal Dystonia Patients
  • Voice Tremor

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brain changes in laryngeal dystonia
Secondary outcome measures
Genes responsible for laryngeal dystonia

Trial Design

4Treatment groups
Experimental Treatment
Group I: Voice tremorExperimental Treatment2 Interventions
Patients with voice tremor will undergo an MRI of the brain and a blood draw.
Group II: Unaffected relatives of laryngeal dystonia patientsExperimental Treatment2 Interventions
Unaffected relatives of patients with laryngeal dystonia will undergo an MRI of the brain and a blood draw.
Group III: Muscle tension dysphoniaExperimental Treatment2 Interventions
Patients with muscle tension dysphonia will undergo an MRI of the brain and a blood draw.
Group IV: Laryngeal DystoniaExperimental Treatment2 Interventions
Patients with laryngeal dystonia will undergo an MRI of the brain and a blood draw.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Blood draw
2021
Completed Phase 4
~7380

Find a Location

Who is running the clinical trial?

Kristina SimonyanLead Sponsor
3 Previous Clinical Trials
334 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
348 Previous Clinical Trials
180,327 Total Patients Enrolled
Kristina Simonyan, MD, PhDPrincipal Investigator - Massachusetts Eye and Ear Infirmary
Massachusetts Eye and Ear Infirmary
8 Previous Clinical Trials
1,824 Total Patients Enrolled
~111 spots leftby Jul 2027